Sodium-glucose co-transporter-2 inhibitors and sacubitril/valsartan combination in patients with heart failure with reduced ejection fraction; does it deserve our attention?

被引：5
|
作者：
Patoulias, Dimitrios [1 ]
Papadopoulos, Christodoulos [2 ]
Doumas, Michael [1 ,3 ]
机构：
[1] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Propedeut Dept Internal Med 2, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Gen Hosp Hippokrat, Dept Cardiol 3, Thessaloniki, Greece
[3] George Washington Univ, Vet Affairs Med Ctr, Washington, DC USA
来源：
AMERICAN HEART JOURNAL | 2021年 / 236卷
关键词：
D O I：
10.1016/j.ahj.2021.02.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [1] Sodium-glucose CO-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [2] Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Monzo, Luca
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Cal, Leonardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 341 : 56 - 59
  • [3] Sodium-glucose CO-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
    Ferrari, Ilaria
    Cicogna, Francesco
    Tota, Claudia
    Calo, Leonardo
    Monzo, Luca
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [4] Promise of sodium-glucose co-transporter-2 inhibitors in heart failure with mildly reduced ejection fraction
    Shen, Xizi
    Shen, Xingping
    ESC HEART FAILURE, 2022, 9 (04): : 2239 - 2248
  • [5] RENAL EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN PATIENTS WITH HEART FAILURE WITH REDUCED OR PRESERVED EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Boulmpou, Aristi
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Zografou, Ioanna
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL 1) : E70 - E70
  • [6] Effect of sodium-glucose co-transporter-2 inhibitors in haemoglobin level of patients with heart failure with reduced ejection fraction
    Catarina Carvalho, C.
    Carvalho, P.
    Bernardo, M.
    Moreira, I.
    Baptista, A.
    Moreira, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 166 - 167
  • [7] Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Karagiannis, Asterios
    Doumas, Michael
    NEFROLOGIA, 2024, 44 (04): : 584 - 585
  • [8] RENAL EFFECTS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS IN PATIENTS WITH HEART FAILURE WITH REDUCED OR PRESERVED EJECTION FRACTION
    Patoulias, Dimitrios
    Katsimardou, Alexandra
    Boulmpou, Aristi
    Siskos, Fotios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Zografou, Ioanna
    Papadopoulos, Christodoulos
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E70 - E70
  • [9] Treatment of heart failure with reduced ejection fraction the dawn of the era of sodium-glucose co-transporter-2 inhibitors
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2020, 41 (36) : 3379 - 3383
  • [10] Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Ventricular Repolarization Markers in Heart Failure with Reduced Ejection Fraction
    Yilmaz, Emre
    Aydin, Ertan
    Camci, Sencer
    Kurt, Devrim
    Aydin, Ercan
    CARDIOVASCULAR DRUGS AND THERAPY, 2024, 38 (02) : 327 - 333
12345